Business Description
bluebird bio Inc
NAICS : 325414
SIC : 2836
ISIN : US09609G1004
Share Class Description:
MEX:BLUE: Ordinary SharesDescription
bluebird bio Inc is a biotechnology company engaged in researching, developing, and commercializing potentially curative gene therapies for severe genetic diseases based on its proprietary lentiviral vector (LVV) gene addition platform. The Company operates in a single segment, focusing on researching, developing and commercializing potentially transformative gene therapies for severe genetic diseases.
Financial Strength
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.19 | |||||
| Equity-to-Asset | -0.01 | |||||
| Debt-to-Equity | -63.67 | |||||
| Debt-to-EBITDA | -1.7 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | -15.57 | |||||
| Beneish M-Score | -3 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 44 | |||||
| 3-Year EPS without NRI Growth Rate | 40.2 | |||||
| 3-Year FCF Growth Rate | 34.8 | |||||
| 3-Year Book Growth Rate | -63.3 | |||||
| Future 3-5Y EPS without NRI Growth Rate | 34.49 | |||||
| Future 3-5Y Total Revenue Growth Rate | 124.08 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 31.46 | |||||
| 9-Day RSI | 21.24 | |||||
| 14-Day RSI | 16.61 | |||||
| 6-1 Month Momentum % | -43.18 | |||||
| 12-1 Month Momentum % | -82.61 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.51 | |||||
| Quick Ratio | 0.33 | |||||
| Cash Ratio | 0.24 | |||||
| Days Inventory | 149.61 | |||||
| Days Sales Outstanding | 128.98 | |||||
| Days Payable | 104.53 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -42.6 | |||||
| Shareholder Yield % | -246.73 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | -48.31 | |||||
| Operating Margin % | -599.54 | |||||
| Net Margin % | -551.26 | |||||
| FCF Margin % | -513.71 | |||||
| ROE % | -245.94 | |||||
| ROA % | -50.94 | |||||
| ROIC % | -60.28 | |||||
| ROC (Joel Greenblatt) % | -99.49 | |||||
| ROCE % | -83.79 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 1.26 | |||||
| EV-to-EBIT | -1.36 | |||||
| EV-to-EBITDA | -1.7 | |||||
| EV-to-Revenue | 6.97 | |||||
| EV-to-Forward-Revenue | 2.33 | |||||
| EV-to-FCF | -1.37 | |||||
| Earnings Yield (Greenblatt) % | -73.76 | |||||
| FCF Yield % | -370.52 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
bluebird bio Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil MXN) | 947.051 | ||
| EPS (TTM) (MXN) | -31.789 | ||
| Beta | -0.42 | ||
| Volatility % | 84.47 | ||
| 14-Day RSI | 16.61 | ||
| 14-Day ATR (MXN) | 0.011135 | ||
| 20-Day SMA (MXN) | 10 | ||
| 12-1 Month Momentum % | -82.61 | ||
| 52-Week Range (MXN) | 9.5 - 57.5 | ||
| Shares Outstanding (Mil) | 194.44 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
bluebird bio Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
bluebird bio Inc Stock Events
| Event | Date | Price(MXN) | ||
|---|---|---|---|---|
| No Event Data | ||||
bluebird bio Inc Frequently Asked Questions
What is bluebird bio Inc(MEX:BLUE)'s stock price today?
The current price of MEX:BLUE is MXN10.00. The 52 week high of MEX:BLUE is MXN57.50 and 52 week low is MXN9.50.
When is next earnings date of bluebird bio Inc(MEX:BLUE)?
The next earnings date of bluebird bio Inc(MEX:BLUE) is 2025-03-26 Est..
Does bluebird bio Inc(MEX:BLUE) pay dividends? If so, how much?
bluebird bio Inc(MEX:BLUE) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers